M. Aapro

Delivering affordable cancer care in high-income countries.

Karol Sikora, Peter Boyle, Paul Catchpole, 2011, The Lancet. Oncology.

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.

M. Kris, F. Roila, R. Gralla, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines†

C. Bokemeyer, M. Aapro, P. Gascón, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group.

M. Piccart, M. Nooij, M. Franchi, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Aprepitant: drug-drug interactions in perspective.

M. Aapro, C. Walko, M. Aapro, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

BONE HEALTH IN CANCER: ESMO CLINICAL PRACTICE GUIDELINES.

M. Aapro, P. Flamen, J. Body, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary.

M. Aapro, V. Morrison, R. Stauder, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer.

C. Porta, A. Ravaud, K. Blackwell, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysis.

M. Aapro, M. Untch, U. Nitz, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron.

M. Aapro, P. Gascón, H. Ludwig, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK).

M. Aapro, B. Thürlimann, H. Neuenschwander, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.